488 studies found for:    "Homologous wasting disease"
Show Display Options
Rank Status Study
1 Recruiting Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
Conditions: Graft Versus Host Disease;   Steroid Refractory GVHD;   Acute GVH Disease
Intervention: Drug: Infliximab and Basiliximab
2 Active, not recruiting Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease
Conditions: Graft vs Host Disease;   Chronic Graft vs Host Disease;   cGVHD
Intervention:
3 Unknown  Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.
Conditions: Graft Versus Host Disease;   Chronic and Expanded Graft Versus Host Disease;   Immune System Diseases
Interventions: Drug: Conventional treatment;   Other: Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue.
4 Recruiting An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease
Conditions: Chronic Graft-versus-Host-Disease;   Oral Mucosal Disease Due to Graft-versus-host Disease
Intervention: Drug: Sirolimus
5 Recruiting Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)
Conditions: Chronic Graft-Versus-Host Disease;   Acute Graft-Versus-Host Disease;   Steroid Refractory Graft-Versus-Host Disease
Interventions: Drug: Rapamycin;   Other: T regulatory cells
6 Completed Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease
Condition: Graft vs Host Disease
Intervention: Drug: Rituximab
7 Recruiting Phase I Trial of Brentuximab Vedotin for Refractory Chronic Graft-vs.-Host Disease (GVHD)
Conditions: Graft-vs-Host Disease;   GVHD
Intervention: Drug: Brentuximab Vedotin
8 Active, not recruiting Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
Condition: Graft vs. Host Disease
Interventions: Drug: Ustekinumab;   Drug: Placebo
9 Completed Cyclosporine Implant for Ocular Graft-Versus-Host Disease
Condition: Graft Vs Host Disease
Intervention: Drug: Subconjunctival Cyclosporine Implant
10 Completed A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-
Conditions: Bone Marrow Transplantation;   Graft Versus Host Disease;   Graft-Versus-Host Disease;   Graft-Vs-Host Disease
Intervention: Drug: Tacrolimus
11 Active, not recruiting Atorvastatin for the Prophylaxis of Acute Graft-versus-host Disease in Patients Undergoing Matched Sibling Allogeneic Transplantation
Condition: Graft vs Host Disease
Intervention: Drug: Atorvastatin calcium (Lipitor)
12 Completed Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant
Conditions: Acute Myelogenous Leukemia (AML);   Acute Lymphocytic Leukemia (ALL);   Graft vs. Host Disease (GvHD)
Intervention: Biological: Thymoglobulin [Anti-Thymocyte Globulin (Rabbit)]
13 Completed Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease
Condition: Graft vs Host Disease
Intervention: Procedure: Extracorporeal Photopheresis
14 Completed Experience of Having Chronic Graft-Versus-Host Disease
Condition: Graft-Versus-Host Disease
Interventions: Behavioral: Interview;   Behavioral: Questionnaire
15 Enrolling by invitation Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease
Condition: Graft-Versus-Host Disease
Intervention:
16 Active, not recruiting Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants
Conditions: Chronic Lymphocytic Leukemia;   Graft vs Host Disease;   Hodgkin's Disease;   Multiple Myeloma;   Non Hodgkin's Lymphoma
Interventions: Drug: Th2 cells in allo HSCTT;   Drug: Th2 Cells
17 Terminated Evaluation of Antifungal Prophylaxis on Graft-versus-host Disease (GVHD) Patients
Condition: Graft vs Host Disease
Intervention: Drug: Itraconazole
18 Recruiting Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease
Condition: Graft vs Host Disease
Intervention: Drug: Topical Dexamethasone
19 Unknown  Combination of Alemtuzumab and Rituximab at Low-doses in Refractory Chronic Graft-Versus-Host Disease
Condition: Graft vs Host Disease
Intervention: Drug: Alemtuzumab and Rituximab combination
20 Completed Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation
Conditions: Acute Myelogenous Leukemia;   Graft Versus Host Disease;   Acute Lymphoblastic Leukemia;   Chronic Myelogenous Leukemia;   Myelodysplastic Syndromes;   Non-Hodgkin's Lymphoma;   Hodgkin's Disease
Interventions: Drug: sirolimus;   Drug: tacrolimus

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years